Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.42 0.00 (0.00%)
As of 10/13/2026 10:44 AM Eastern

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Advanced

Key Stats

Today's Range
$0.42
▼
$0.42
50-Day Range
$0.35
▼
$0.58
52-Week Range
$0.32
▼
$0.65
Volume
13,000 shs
Average Volume
5,790 shs
Market Capitalization
$9.62 million
P/E Ratio
42.04
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharma-Bio Serv, Inc. is a professional services and consulting company serving the pharmaceutical, biotechnology, medical device, and related healthcare industries. The company helps clients address technical, regulatory, quality, and compliance requirements associated with the development, manufacture, and operation of regulated products and facilities.

Its services have included regulatory compliance support, validation, quality systems, project management, engineering, and construction management. Pharma-Bio Serv works with companies on activities such as facility and process implementation, documentation, inspections, and maintaining compliance with applicable industry standards and government regulations.

The company was established in Puerto Rico and has provided services to clients in Puerto Rico, the United States, and other international markets. Publicly available information about its current leadership and detailed operating structure is limited; therefore, no specific leadership information is included here.

AI Generated. May Contain Errors.

Pharma-Bio Serv Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

PBSV MarketRank™: 
1.28164556962 of 5 stars

Pharma-Bio Serv scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pharma-Bio Serv.

  • Earnings Growth

    Earnings for Pharma-Bio Serv are expected to grow by 175.00% in the coming year, from $0.04 to $0.11 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharma-Bio Serv is 42.04, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 35.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharma-Bio Serv is 42.04, which means that it is trading at a more expensive P/E ratio than the Industrials sector average P/E ratio of about 23.43.

  • Price to Book Value per Share Ratio

    Pharma-Bio Serv has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of Pharma-Bio Serv has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 0.15, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharma-Bio Serv has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pharma-Bio Serv does not currently pay a dividend.

  • Dividend Growth

    Pharma-Bio Serv does not have a long track record of dividend growth.

  • News Sentiment

    Pharma-Bio Serv has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Pharma-Bio Serv this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.60% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Pharma-Bio Serv has minimal institutional ownership at this time.

  • Read more about Pharma-Bio Serv's insider trading history.
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBSV Stock News Headlines

Pharma-Bio Serv (PBSV)
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
PBSV is a Small Stock Worth a Look
PBSV Showing Improved Operations and Strong Dividend
PBSV Has Great Yield and Improved Operations
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.60 on January 1st, 2026. Since then, PBSV stock has decreased by 30.0% and is now trading at $0.42.

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) issued its earnings results on Monday, June, 15th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.02. The company had revenue of $2.70 billion for the quarter, compared to analysts' expectations of $2.70 million. Pharma-Bio Serv had a trailing twelve-month return on equity of 2.34% and a net margin of 2.66%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
6/15/2026
Today
10/14/2026
Fiscal Year End
10/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
CIK
1304161
Employees
185
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
42.04
Forward P/E Ratio
10.50
P/E Growth
N/A
Net Income
-$100 thousand
Net Margins
2.66%
Pretax Margin
2.83%
Return on Equity
2.34%
Return on Assets
2.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.30
Quick Ratio
11.30

Sales & Book Value

Annual Sales
$9 million
Price / Sales
1.07
Cash Flow
$0.00 per share
Price / Cash Flow
86.00
Book Value
$0.52 per share
Price / Book
0.81

Miscellaneous

Outstanding Shares
22,900,000
Free Float
20,016,000
Market Cap
$9.62 million
Optionable
Not Optionable
Beta
0.69

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners